Associations of Opium Use with Metabolic Syndrome in Fasa PERSIAN Cohort Study: A Population-Based Study

Background: This study aimed to determine the relationships between opium use and metabolic syndrome in Fasa PERSIAN cohort data. Methods: This was an analytical cross-sectional study conducted among participants of the first phase of the Fasa PERSIAN cohort study. A total of 10,074 participants (ag...

Full description

Saved in:
Bibliographic Details
Main Authors: Rafat Shadmehr, Mehdi Sharafi, Mohammadhossien Shahabzadeh, Mostafa Bijani, Rahim Sharafkhani, Babak Pezeshki, Abdolmajid Ghasemian, Azizallah Dehghan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:International Journal of Preventive Medicine
Subjects:
Online Access:https://journals.lww.com/10.4103/ijpvm.ijpvm_164_23
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860331704745984
author Rafat Shadmehr
Mehdi Sharafi
Mohammadhossien Shahabzadeh
Mostafa Bijani
Rahim Sharafkhani
Babak Pezeshki
Abdolmajid Ghasemian
Azizallah Dehghan
author_facet Rafat Shadmehr
Mehdi Sharafi
Mohammadhossien Shahabzadeh
Mostafa Bijani
Rahim Sharafkhani
Babak Pezeshki
Abdolmajid Ghasemian
Azizallah Dehghan
author_sort Rafat Shadmehr
collection DOAJ
description Background: This study aimed to determine the relationships between opium use and metabolic syndrome in Fasa PERSIAN cohort data. Methods: This was an analytical cross-sectional study conducted among participants of the first phase of the Fasa PERSIAN cohort study. A total of 10,074 participants (aged 35–70 years) were studied. The MetS was defined as per the National Cholesterol Education Program ATP III (NCEP-ATP III) criteria. Independent sample t-test and Chi-square test were used for univariate analysis, and multivariate logistic regression was used to control for potential confounders and calculate odds ratios (ORs). Results: The MetS prevalence was 24.6% in the whole population (28.42% in women vs. 19.94% in men, P < 0.001). The prevalence of opium use was 23.2%. The odds of metabolic syndrome in smokers was lower than in non-smokers (OR = 1.17%, 95% CI 1.001–1.37). Conclusions: The results of this study showed that opium consumption has an inverse relationship with metabolic syndrome. However, this study was cross-sectional, and longitudinal studies are needed for more accurate conclusions. Opium is also a carcinogen. Therefore, its use is not recommended.
format Article
id doaj-art-2dbeddffe4ba45fbb7660e23ef414bc9
institution Kabale University
issn 2008-7802
2008-8213
language English
publishDate 2025-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series International Journal of Preventive Medicine
spelling doaj-art-2dbeddffe4ba45fbb7660e23ef414bc92025-02-10T15:22:27ZengWolters Kluwer Medknow PublicationsInternational Journal of Preventive Medicine2008-78022008-82132025-01-011614410.4103/ijpvm.ijpvm_164_23Associations of Opium Use with Metabolic Syndrome in Fasa PERSIAN Cohort Study: A Population-Based StudyRafat ShadmehrMehdi SharafiMohammadhossien ShahabzadehMostafa BijaniRahim SharafkhaniBabak PezeshkiAbdolmajid GhasemianAzizallah DehghanBackground: This study aimed to determine the relationships between opium use and metabolic syndrome in Fasa PERSIAN cohort data. Methods: This was an analytical cross-sectional study conducted among participants of the first phase of the Fasa PERSIAN cohort study. A total of 10,074 participants (aged 35–70 years) were studied. The MetS was defined as per the National Cholesterol Education Program ATP III (NCEP-ATP III) criteria. Independent sample t-test and Chi-square test were used for univariate analysis, and multivariate logistic regression was used to control for potential confounders and calculate odds ratios (ORs). Results: The MetS prevalence was 24.6% in the whole population (28.42% in women vs. 19.94% in men, P < 0.001). The prevalence of opium use was 23.2%. The odds of metabolic syndrome in smokers was lower than in non-smokers (OR = 1.17%, 95% CI 1.001–1.37). Conclusions: The results of this study showed that opium consumption has an inverse relationship with metabolic syndrome. However, this study was cross-sectional, and longitudinal studies are needed for more accurate conclusions. Opium is also a carcinogen. Therefore, its use is not recommended.https://journals.lww.com/10.4103/ijpvm.ijpvm_164_23metabolic syndromeopiumwaist circumference fasa
spellingShingle Rafat Shadmehr
Mehdi Sharafi
Mohammadhossien Shahabzadeh
Mostafa Bijani
Rahim Sharafkhani
Babak Pezeshki
Abdolmajid Ghasemian
Azizallah Dehghan
Associations of Opium Use with Metabolic Syndrome in Fasa PERSIAN Cohort Study: A Population-Based Study
International Journal of Preventive Medicine
metabolic syndrome
opium
waist circumference fasa
title Associations of Opium Use with Metabolic Syndrome in Fasa PERSIAN Cohort Study: A Population-Based Study
title_full Associations of Opium Use with Metabolic Syndrome in Fasa PERSIAN Cohort Study: A Population-Based Study
title_fullStr Associations of Opium Use with Metabolic Syndrome in Fasa PERSIAN Cohort Study: A Population-Based Study
title_full_unstemmed Associations of Opium Use with Metabolic Syndrome in Fasa PERSIAN Cohort Study: A Population-Based Study
title_short Associations of Opium Use with Metabolic Syndrome in Fasa PERSIAN Cohort Study: A Population-Based Study
title_sort associations of opium use with metabolic syndrome in fasa persian cohort study a population based study
topic metabolic syndrome
opium
waist circumference fasa
url https://journals.lww.com/10.4103/ijpvm.ijpvm_164_23
work_keys_str_mv AT rafatshadmehr associationsofopiumusewithmetabolicsyndromeinfasapersiancohortstudyapopulationbasedstudy
AT mehdisharafi associationsofopiumusewithmetabolicsyndromeinfasapersiancohortstudyapopulationbasedstudy
AT mohammadhossienshahabzadeh associationsofopiumusewithmetabolicsyndromeinfasapersiancohortstudyapopulationbasedstudy
AT mostafabijani associationsofopiumusewithmetabolicsyndromeinfasapersiancohortstudyapopulationbasedstudy
AT rahimsharafkhani associationsofopiumusewithmetabolicsyndromeinfasapersiancohortstudyapopulationbasedstudy
AT babakpezeshki associationsofopiumusewithmetabolicsyndromeinfasapersiancohortstudyapopulationbasedstudy
AT abdolmajidghasemian associationsofopiumusewithmetabolicsyndromeinfasapersiancohortstudyapopulationbasedstudy
AT azizallahdehghan associationsofopiumusewithmetabolicsyndromeinfasapersiancohortstudyapopulationbasedstudy